Cargando…

Enhanced Immunomodulatory Effect of Intravenous Immunoglobulin by Fc Galactosylation and Nonfucosylation

Intravenous immunoglobulin (IVIG) is used as an immunomodulatory agent in the treatment of various autoimmune/inflammatory diseases although its mechanism of action remains elusive. Recently, nonfucosylated IgG has been shown to be preferentially bound to Fcγ receptor IIIa (FcγRIIIa) on circulating...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mimura, Yusuke, Mimura-Kimura, Yuka, Saldova, Radka, Rudd, Pauline M., Jefferis, Roy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8831331/ https://www.ncbi.nlm.nih.gov/pubmed/35154135 http://dx.doi.org/10.3389/fimmu.2022.818382

Ejemplares similares

Erratum: Enhanced Immunomodulatory Effect of Intravenous Immunoglobulin by Fc Galactosylation and Nonfucosylation
Publicado: (2022)

Nonfucosylation of an anti-TIGIT antibody enhances FcγR engagement, driving innate immune activation and antitumor activity
por: Smith, Alyson J., et al.
Publicado: (2023)

Fc-Galactosylation of Human Immunoglobulin Gamma Isotypes Improves C1q Binding and Enhances Complement-Dependent Cytotoxicity
por: Peschke, Benjamin, et al.
Publicado: (2017)

Glycosylation engineering of therapeutic IgG antibodies: challenges for the safety, functionality and efficacy
por: Mimura, Yusuke, et al.
Publicado: (2017)

Novel Concepts of Altered Immunoglobulin G Galactosylation in Autoimmune Diseases
por: Dekkers, Gillian, et al.
Publicado: (2018)

Fc galactosylation follows consecutive reaction kinetics and enhances immunoglobulin G hexamerization for complement activation
por: Wei, Bingchuan, et al.
Publicado: (2021)

Specific location of galactosylation in an afucosylated antiviral monoclonal antibody affects its FcγRIIIA binding affinity
por: Hatfield, Grayson, et al.
Publicado: (2022)

NBTXR3 improves the efficacy of immunoradiotherapy combining nonfucosylated anti-CTLA4 in an anti-PD1 resistant lung cancer model
por: Hu, Yun, et al.
Publicado: (2022)

Neonatal Fc receptor induces intravenous immunoglobulin growth suppression in Langerhans cell histiocytosis
por: Nabeshima, Yuka, et al.
Publicado: (2021)

Comprehensive N-Glycan Profiling of Avian Immunoglobulin Y
por: Gilgunn, Sarah, et al.
Publicado: (2016)

The effect of FcγRIIA and FcγRIIB on coronary artery lesion formation and intravenous immunoglobulin treatment responses in children with Kawasaki disease
por: Chang, Ling-Sai, et al.
Publicado: (2016)

Fc galactosylation of anti-platelet human IgG1 alloantibodies enhances complement activation on platelets
por: van Osch, Thijs L.J., et al.
Publicado: (2022)

ICOS-Fc as innovative immunomodulatory approach to counteract inflammation and organ injury in sepsis
por: Alves, Gustavo Ferreira, et al.
Publicado: (2022)

IgG Fc galactosylation predicts response to methotrexate in early rheumatoid arthritis
por: Lundström, Susanna L., et al.
Publicado: (2017)

Immunoglobulin Glycosylation – An Unexploited Potential for Immunomodulatory Strategies in Farm Animals
por: Zlatina, Kristina, et al.
Publicado: (2021)

IgG1 Fc N-glycan galactosylation as a biomarker for immune activation
por: de Jong, Sanne E., et al.
Publicado: (2016)

Immunomodulation: Immunoglobulin Preparations Suppress Hyperinflammation in a COVID-19 Model via FcγRIIA and FcαRI
por: Bohländer, Fabian, et al.
Publicado: (2021)

Reversing Autoimmunity Combination of Rituximab and Intravenous Immunoglobulin
por: Ahmed, A. Razzaque, et al.
Publicado: (2018)

The Ability of Zika virus Intravenous Immunoglobulin to Protect From or Enhance Zika Virus Disease
por: Pinto, Amelia K., et al.
Publicado: (2021)

Glycosylation Changes on Serum Glycoproteins in Ovarian Cancer May Contribute to Disease Pathogenesis
por: Saldova, Radka, et al.
Publicado: (2008)

Abnormal N‐glycan fucosylation, galactosylation, and sialylation of IgG in adults with classical galactosemia, influence of dietary galactose intake
por: Treacy, Eileen P., et al.
Publicado: (2021)

Comparison of biological activities of human antithrombins with high-mannose or complex-type nonfucosylated N-linked oligosaccharides
por: Yamada, Tsuyoshi, et al.
Publicado: (2016)

Immunoglobulin Fc Heterodimer Platform Technology: From Design to Applications in Therapeutic Antibodies and Proteins
por: Ha, Ji-Hee, et al.
Publicado: (2016)

Comparison of Fc N-Glycosylation of Pharmaceutical Products of Intravenous Immunoglobulin G
por: Fokkink, Willem Jan R., et al.
Publicado: (2015)

Synthesis and biological activity of α-galactosyl ceramide KRN7000 and galactosyl (α1→2) galactosyl ceramide
por: Veerapen, Natacha, et al.
Publicado: (2009)

High-Dose Intravenous Immunoglobulin in Skin Autoimmune Disease
por: Hoffmann, Jochen H. O., et al.
Publicado: (2019)

Therapeutic Potential of Intravenous Immunoglobulin in Acute Brain Injury
por: Thom, Vivien, et al.
Publicado: (2017)

Immunomodulatory effects of different intravenous immunoglobulin preparations in chronic lymphocytic leukemia
por: Colado, Ana, et al.
Publicado: (2021)

Dengue vascular leakage is augmented by mast cell degranulation mediated by immunoglobulin Fcγ receptors
por: Syenina, Ayesa, et al.
Publicado: (2015)

Corrigendum: Immunoglobulin Fc Heterodimer Platform Technology: From Design to Applications in Therapeutic Antibodies and Proteins
por: Ha, Ji-Hee, et al.
Publicado: (2017)

Immunoglobulin domain interface exchange as a platform technology for the generation of Fc heterodimers and bispecific antibodies
por: Skegro, Darko, et al.
Publicado: (2017)

Vectorized Delivery of Alpha-GalactosylCeramide and Tumor Antigen on Filamentous Bacteriophage fd Induces Protective Immunity by Enhancing Tumor-Specific T Cell Response
por: Sartorius, Rossella, et al.
Publicado: (2018)

Is It Safe to Switch From Intravenous Immunoglobulin to Subcutaneous Immunoglobulin in Patients With Common Variable Immunodeficiency and Autoimmune Thrombocytopenia?
por: Scheuerlein, Philipp, et al.
Publicado: (2018)

Altered Fc galactosylation in IgG(4) is a potential serum marker for chronic lung disease
por: Heyder, Tina, et al.
Publicado: (2018)

Intravenous Immunoglobulin and Immunomodulation of B-Cell – in vitro and in vivo Effects
por: Mitrevski, Milica, et al.
Publicado: (2015)

Parameter Identification for a Model of Neonatal Fc Receptor-Mediated Recycling of Endogenous Immunoglobulin G in Humans
por: Kendrick, Felicity, et al.
Publicado: (2019)

mRNA vaccines against SARS-CoV-2 induce comparably low long-term IgG Fc galactosylation and sialylation levels but increasing long-term IgG4 responses compared to an adenovirus-based vaccine
por: Buhre, Jana Sophia, et al.
Publicado: (2023)

Anti-D monoclonal antibodies from 23 human and rodent cell lines display diverse IgG Fc-glycosylation profiles that determine their clinical efficacy
por: Kumpel, Belinda M., et al.
Publicado: (2020)

Greedy feature selection for glycan chromatography data with the generalized Dirichlet distribution
por: Galligan, Marie C, et al.
Publicado: (2013)

Low pH Exposure During Immunoglobulin G Purification Methods Results in Aggregates That Avidly Bind Fcγ Receptors: Implications for Measuring Fc Dependent Antibody Functions
por: Lopez, Ester, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_kkiojpa0e6jng4nd4hb3fhgpdd